A comparative national survey on the gradual decline of hepatitis C virus prevalence in Thailand, 2004, 2014, and 2024

A comparative national survey on the gradual decline of hepatitis C virus prevalence in Thailand, 2004, 2014, and 2024

Abstract This study investigates the seroprevalence and trends of Hepatitis C virus (HCV) infection in Thailand in 2024 through a nationwide serosurvey. A cross-sectional study was conducted from May to July 2024, recruiting 6069 participants aged 6 months to 80 years from four provinces representin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sitthichai Kanokudom, Pornjarim Nilyanimit, Jiratchaya Puenpa, Nungruthai Suntronwong, Duong Hoang Huy Le, Lakkhana Wongsrisang, Sirapa Klinfueng, Prangnapitch Wihanthong, Narong Thawinwisan, Pichet Puedkuntod, Watcharanan Tinnaitorn, Pornsawan Meechin, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-06-01
Series:	Scientific Reports
Subjects:	Hepatitis C elimination Seroprevalence The Elecsys® HCV Duo-assay (Duo-assay) Anti-HCV HCV core antigen (HCVcAg)
Online Access:	https://doi.org/10.1038/s41598-025-04578-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Performance of Elecsys<sup>®</sup> HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection
by: Prooksa Ananchuensook, et al.
Published: (2024-09-01)

HIV testing algorithm using fourth generation reagents reduces the false positive rate of screening tests
by: Yu Gou, et al.
Published: (2025-04-01)

Reflex threshold of signal-to-cut-off ratios of the Elecsys anti-HCV II assay for hepatitis C virus infection
by: Jie Pan, et al.
Published: (2016-09-01)

Hepatitis C Virus—Core Antigen: Implications in Diagnostic, Treatment Monitoring and Clinical Outcomes
by: Duong Hoang Huy Le, et al.
Published: (2024-11-01)

Hepatitis C virus genotypes and viremia in a tertiary hospital in Istanbul, Turkey
by: Sema Alacam, et al.
Published: (2022-04-01)

The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey
by: Bülent Dabanlıoğlu, et al.
Published: (2024-01-01)

CL-duo modules
by: Muna Abbas Ahmed
Published: (2017-10-01)

Prevalence of anti-hepatitis C virus antibodies in pregnant women and their offspring in a tertiary hospital in Southwestern Nigeria
by: Paul Sunday Ogunro, et al.
Published: (2007-12-01)

Dried blood spot as alternative specimen for molecular epidemiology studies among HCV/HIV coinfected patients
by: Geane Flores, et al.
Published: (2025-03-01)

The prevalence of the hepatitis C virus among the conditionally healthy population of the Russian Federation
by: N. V. Soboleva, et al.
Published: (2017-06-01)

CL-duo modules
by: Baghdad Science Journal
Published: (2017-09-01)

Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years
by: Pietro Torre, et al.
Published: (2024-11-01)

HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study
by: Yaping He, et al.
Published: (2024-11-01)

Сучасний погляд на профілактику акушерських та перинатальних ускладнень у жінок із HCV-інфекцією
by: K.V. Chaika, et al.
Published: (2022-03-01)

Prevalence and Risk Factors of Occult HCV Infection in the Adult Population of Mexico City
by: Luis Antonio Uribe-Noguez, et al.
Published: (2025-02-01)

Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors
by: Enagnon Kazali Alidjinou, et al.
Published: (2014-08-01)

Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
by: Fatih Mehmet Akıllı
Published: (2024-12-01)

Hepatitis C Virus NS5A Activates Mitophagy Through Cargo Receptor and Phagophore Formation
by: Yuan-Chao Hsiao, et al.
Published: (2024-12-01)

Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection
by: Andrea Magri, et al.
Published: (2024-12-01)

Coinfection with HIV-1 skews iNKT cells toward TCR anergy and limited expansion potential in people with hepatitis C
by: Danielle Nettere, et al.
Published: (2025-04-01)

Autoimmunity and Lymphoma: Splenic Marginal Zone Lymphoma with Scleroderma and Chronic Hepatitis C Virus infection.
by: Ricardo García-Muñoz
Published: (2014-08-01)

Pathway to hepatitis C elimination: insights from a large tertiary hospital in South China
by: Suling Chen, et al.
Published: (2025-12-01)

Dynamic changes in the prevalence of markers of hepatitis C virus infection among the conditionally healthy population of the Tyva Republic
by: A. A. Saryglar, et al.
Published: (2024-01-01)

Threshold value of the anti-HCV test in the diagnosis of HCV infection
by: Özlem Kirişci, et al.
Published: (2019-10-01)

HLA-G liver expression in chronically HIV/hepatitis C-coinfected individuals.
by: Fernando Crivelenti Vilar, et al.
Published: (2025-01-01)

Persistent Low Anti-HIV Neutralizing Antibody Titers in HIV/HCV Coinfection Despite HCV Cure: A 5-Year Longitudinal Analysis
by: Daniel Sepúlveda-Crespo, et al.
Published: (2025-05-01)

RESEARCH DATA ON THE PREVALENCE OF HEPATITIS C VIRUS ANTIBODIESAMONG INPATIENTS AT A HOSPITAL IN CENTRAL BULGARIA: 2021 –2022
by: A.Gotseva, et al.
Published: (2024-09-01)

HEPATITIS C VIRUS INFECTION AND LYMPHOMA
by: Felipe Suarez, et al.
Published: (2010-02-01)

Seropositivity and coinfection of hepatitis B and hepatitis C viruses in Central India: A hospital-based study
by: Rajeev K. Jain, et al.
Published: (2024-10-01)

Hepatocellular carcinoma in a non-cirrhotic liver of a HCV-positive woman with sustained viral response
by: Gianfranco Costanzo, et al.
Published: (2011-01-01)

HEPATITIS C VIRUS INFECTION AND LYMPHOMA
by: Emmanuel Bachy, et al.
Published: (2010-03-01)

Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan
by: Muhammad Sohail Afzal, et al.
Published: (2011-01-01)

HCV and HIV co-infection among people who inject drugs in Vietnam
by: Vu Toan THINH, et al.
Published: (2020-12-01)

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients
by: Ana Virseda-Berdices, et al.
Published: (2025-01-01)

Getting to full disclosure: HCV testing and status disclosure behaviors among PWID and their injecting partners
by: Maia Scarpetta, et al.
Published: (2025-05-01)

Hepatitis C Infection Confirmation and Fewer Visits Contribute to Improving Treatment Rates in a Predominantly African American Health Center
by: Crisshy Auguste, et al.
Published: (2024-11-01)

A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You’re Empowered for Treatment Initiation (YETI) partner trial
by: Meghan D. Morris, et al.
Published: (2025-01-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

Knowledge, attitudes, and prevention practices for hepatitis B and C virus infection among patients in the North Gondar zone, Northwest Ethiopia
by: Yideg Abinew, et al.
Published: (2025-07-01)

The characteristic of lethality as an indicator of combinad infections
by: V. V. Nechaev, et al.
Published: (2016-04-01)